LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancerWeiwei Tang, Suryavathi Viswanadhapalli|Cell Death Discovery|2021Cited by 35
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancersSuryavathi Viswanadhapalli, Ratna K. Vadlamudi|Breast Cancer Research|2019Cited by 26